SavedAdd your journal

Journals / Haydarpaşa Numune Medical Journal / 2021 / Cilt: 61 - Sayı: 4

Seroprevalence of Toxoplasma Gondii Antibodies in Pregnant Women in Thrace Region of Turkey - A Tertiary Center Experience

Cem YENER
Füsun VAROL
Işıl UZUN
Cenk SAYIN
Sinan ATEŞ
Havva SÜTCÜ
Burcu YEŞİLDAĞ
Birsen BAŞAR
Pages
445–450
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Screening during the first trimester would be appropriate and prenatal education should be given to the patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The objective of the study is to investigate Toxoplasma gondii antibody seroprevalence in pregnancies who applied for prenatal care to the tertiary center in Trakya (Thrace) Region of Turkey between January 01, 2014, and December 31, 2018, retrospectively.
📊
Key Findings & Data:Methods: This study retrospectively analyzes seroprevalence of T. gondii IgM and IgG antibodies of 2.317 pregnant patients in their first trimester attended to the Obstetrics and Gynecology Antenatal Care Unit in Trakya University, Faculty of Medicine between January 01, 2014, and December 31, 2018.
💡
Conclusion & Impact:Screening during the first trimester would be appropriate and prenatal education should be given to the patients.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: The objective of the study is to investigate Toxoplasma gondii antibody seroprevalence in pregnancies who applied for prenatal care to the tertiary center in Trakya (Thrace) Region of Turkey between January 01, 2014, and December 31, 2018, retrospectively. Methods: This study retrospectively analyzes seroprevalence of T. gondii IgM and IgG antibodies of 2.317 pregnant patients in their first trimester attended to the Obstetrics and Gynecology Antenatal Care Unit in Trakya University, Faculty of Medicine between January 01, 2014, and December 31, 2018. For this purpose, IgM, IgG and if necessary, IgG avidity results were evaluated. Results: In our study period 2.317 pregnant women were analyzed. 1.630 pregnant women (70.3%) were IgG and IgM seronegative, 607 (26.1%) were IgG seropositive, 61 (2.6%) were both IgG and IgM seropositive and 19 (0.9%) were only IgM positive. 30 of 61 patients with both IgG and IgM seropositivity showed low avidity. After 2 weeks for seroconversion control, in 16 of the patients with just IgM positivity, only 3 18.7%) showed seroconversion. We excluded patients who did not participate our routine follow-ups. Discussion and Conclusion: Even toxoplasma exposure rate in the pregnant women from the Trakya Region of Turkey is high (26.1%) before pregnancy, about 70% of first-trimester pregnant patients were found seronegative. Screening during the first trimester would be appropriate and prenatal education should be given to the patients.

🔖

Cite This Article

YENER, C., VAROL, F., UZUN, I., SAYIN, C., ATEŞ, S., SÜTCÜ, H., YEŞİLDAĞ, B., BAŞAR, B. (2022). Seroprevalence of Toxoplasma Gondii Antibodies in Pregnant Women in Thrace Region of Turkey - A Tertiary Center Experience. Haydarpaşa Numune Medical Journal, Cilt: 61 - Sayı: 4, 445–450. https://ajindex.com/articles/535900

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Elsheikha HM. Congenital toxoplasmosis: Priorities for further health promotion action. Public Health. 2008;122:335–53
  2. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363:1965–76
  3. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 2009;39:1385–94
  4. De Paschale M, Agrappi C, Manco MT, Cerulli T, Clerici P. Implementation of screening for Toxoplasma gondii infection in pregnancy. J Clin Med Res 2010;2:112–6
  5. Nimri L, Pelloux H, Elkhatib H. Detection of T. gondii DNA and specific antibodies in high-risk pregnant women. Am J Trop Med Hyg 2004;71:831–5
  6. Villena I, Chemla C, Quereux C, Dupouy D, Leroux B, Foudrinier F. Prenatal diagnosis of congenital toxoplasmosis transmitted by an immuno-competent woman infected before conception. Reims toxoplasmosis group. Prenat Diagn 1998;18:1079– 81
  7. Hernandez J, Bonobio M, Perea E. IgG avidity for toxoplasmosis detection by the Liason system. Clin Microbiol Infect 2003;9:254
  8. Doğan K, Kafkaslı A, Karaman Ü, Atambay M, Karaoğlu L, Çolak C. Gebelerde Toksoplazma enfeksiyonunun seropozitiflik ve serokonversiyon oranları. Mikrobiyol Bul 2012; 46:290–4
  9. Bayman G, Suay A, Atmaca S, Yayla M. Gebelerde toksoplazma seropozitifliği. Turkiye Parazitol Derg 1998;22:359–61
  10. Kolgelier S, Demiraslan H, Kataş B, Guler D. Gebelerde Toxoplasma gondii seroprevalansı. Dicle Tıp Derg 2009;36:170–2
  11. Tekay F, Ozbek E. The seroprevalence of Toxoplasma gondii in women from Sanliurfa, a province with a high raw meatball consumption. Turkiye Parazitol Derg 2007;31:176–9
  12. Pekinturk N, Cekin Y, Gur N. Antalya ilinde bir mikrobiyoloji laboratuvarına Toxoplasma gondii antikorları araştırılması amacıyla başvuran doğurganlık yaş grubu kadın olgulara ait sonuçların retrospektif olarak değerlendirilmesi. Turk Parazitol Derg 2012;36:96–9
  13. Villena I, Ancelle T, Delmas C. Congenital toxoplasmosis in France in 2007: First results from a national surveillance system. Euro Surveill 2010;15:19600
  14. Aspöck H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis 1992;84:32–7
  15. Lopez A, Dietz VJ, Wilson M, Navin TR, Jones JL. Preventing congenital toxoplasmosis. MMWR Recomm Rep 2000;49:59– 68
  16. Varol FG, Sayın C, Soysüren S. Trakya yöresinde antenatal bakım alan gebelerde toxoplasma gondi antikor seroprevalansı.